Kobayashi in ¥500 billion buyout talks after red-yeast case
Kobayashi Pharmaceutical, the Japanese health products company that was at the center of a supplement contamination scandal involving…
Seth Fischer’s Sohn Tour to Talk Japan Stocks, Support Cancer Research
There are road warriors, and then there’s Seth Fischer. The founder of Oasis Management, a Hong Kong-based hedge…